Effect of Electroacupuncture on Patients Undergoing Heart Surgery
Investigation of the Hemodynamic, Cardioprotective and Anti-inflammatory Effectiveness of Electroacupuncture in Patients Undergoing Coronary Artery Bypass Surgery: Randomized, Controlled Study.
This study tests if electroacupuncture can help patients feel better during and after heart surgery by comparing it to a control group that doesn't receive the treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Kahramanmaras Sutcu Imam University Academic / other |
| Locations | 1 site (Kahramanmaraş) |
| Trial ID | NCT06110780 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of electroacupuncture in patients undergoing coronary artery bypass surgery. It is a prospective, randomized, and controlled trial where participants will be divided into two groups: one receiving electroacupuncture and the other serving as a control. The acupuncture will be applied at specific points believed to influence cardiovascular function, and various patient metrics will be recorded to assess outcomes. The study aims to evaluate the potential protective effects of electroacupuncture during cardiac surgery.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with an ASA classification of III, who are undergoing elective coronary artery bypass surgery.
Not a fit: Patients with systemic diseases, chronic inflammatory conditions, or those requiring emergency surgery may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance recovery and reduce complications for patients undergoing heart surgery.
How similar studies have performed: While acupuncture has been used in various contexts, this specific application in cardiac surgery is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * American Society of Anesthesiologists (ASA) classification III, * 18-65 years old, * Conscious Open, * Participating in the study and giving permission to practice acupuncture, * Does not require emergency or repeat surgery, * Ejection/Fraction (E/F) ratio of 50-55% * Patients extubated within 24 hours after transfer to intensive care Exclusion Criteria: * Patients who do not want to participate in the study, * Patients with systemic diseases such as advanced liver, kidney and lung disease, * Those with chronic inflammatory diseases (rheumatoid arthritis and psoriasis), * Patients receiving immune systemic therapy, * Patients with poor mental status, * Patients with a history of epilepsy, * Patients with pacemakers, * Patients who have had heart surgery and emergency within the last month, * Patients with atrial fibrillation, * Patients who have atrial fibrillation and cannot be measured after coming off the pump, * Patients who were not extubated within 24 hours after transfer to intensive care were excluded from the study. * Additionally, patients receiving the antidiabetic sulfonylurea or glibenclamide were excluded because these agents have been shown to abolish the cardioprotective effect elicited by ischemic preconditioning.
Where this trial is running
Kahramanmaraş
- Kahramanmaras Sutcu Imam University Faculty of Medicine — Kahramanmaraş, Turkey (Recruiting)
Study contacts
- Principal investigator: Yavuz Orak — Kahramanmaras Sutcu Imam University Faculty Medicine, anesthesiology and Reanimation Department
- Study coordinator: Yavuz Orak
- Email: dryavuzorak@hotmail.com
- Phone: 905334717056
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.